862 related articles for article (PubMed ID: 20637964)
1. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
[TBL] [Abstract][Full Text] [Related]
2. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
Luskin A; Bukstein D; Kocevar VS; Yin DD
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
[TBL] [Abstract][Full Text] [Related]
3. Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone.
Allen-Ramey FC; Markson LE; Riedel AA; Sajjan S; Weiss KB
Curr Med Res Opin; 2006 Aug; 22(8):1453-61. PubMed ID: 16870071
[TBL] [Abstract][Full Text] [Related]
4. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
Allen-Ramey FC; Anstatt DT; Sajjan SG; Markson LE
Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
[TBL] [Abstract][Full Text] [Related]
5. Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy.
Sazonov-Kocevar V; Laforest L; Travier N; Yin DD; Van Ganse E
Pediatr Allergy Immunol; 2006 Dec; 17(8):620-8. PubMed ID: 17121591
[TBL] [Abstract][Full Text] [Related]
6. Cost, utilization, and patterns of medication use associated with chronic idiopathic urticaria.
Zazzali JL; Broder MS; Chang E; Chiu MW; Hogan DJ
Ann Allergy Asthma Immunol; 2012 Feb; 108(2):98-102. PubMed ID: 22289728
[TBL] [Abstract][Full Text] [Related]
7. Adherence to asthma controller medication regimens.
Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
[TBL] [Abstract][Full Text] [Related]
8. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected].
Bousquet J; Gaugris S; Kocevar VS; Zhang Q; Yin DD; Polos PG; Bjermer L
Clin Exp Allergy; 2005 Jun; 35(6):723-7. PubMed ID: 15969661
[TBL] [Abstract][Full Text] [Related]
10. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
[TBL] [Abstract][Full Text] [Related]
11. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
12. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
13. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
[TBL] [Abstract][Full Text] [Related]
14. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
[TBL] [Abstract][Full Text] [Related]
15. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.
Stempel DA; Mauskopf J; McLaughlin T; Yazdani C; Stanford RH
Respir Med; 2001 Mar; 95(3):227-34. PubMed ID: 11266241
[TBL] [Abstract][Full Text] [Related]
16. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
17. The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.
Davies GM; Dasbach EJ; Santanello NC; Knorr BA; Bratton DL
Clin Ther; 2004 Nov; 26(11):1895-904. PubMed ID: 15639701
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
19. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
